N
IMA

Nuveen’s ImageneBio Inc IMA Stock Holding History

Nuveen’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,027
Closed -$51.6K – 3374
2024
Q1 		$51.6K Hold
3,027
– – ﹤0.01% 3268
2023
Q4 		$71.6K Buy
3,027
+275
+10% +$8.97K ﹤0.01% 3298
2023
Q3 		$143K Hold
2,752
– – ﹤0.01% 3085
2023
Q2 		$217K Buy
+2,752
New +$197K ﹤0.01% 3084
2022
Q2 		– Sell
-6,176
Closed -$540K – 3366
2022
Q1 		$540K Buy
6,176
+110
+2% +$11.7K ﹤0.01% 2990
2021
Q4 		$997K Buy
6,066
+3,309
+120% +$537K ﹤0.01% 2863
2021
Q3 		$429K Buy
2,757
+502
+22% +$73K ﹤0.01% 3195
2021
Q2 		$379K Buy
+2,255
New +$497K ﹤0.01% 3194

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen's IMA Position: Q2 2024 in Review

Nuveen sold out of ImageneBio Inc (IMA) in Q2 2024, closing a stake of 3,027 shares — an estimated $51.6K sold.

Nuveen first reported a position in IMA in Q2 2021 and held it in 8 quarters. The position peaked at $997K in Q4 2021. 70 funds tracked by Wall St. Rank hold IMA as of Q2 2024.

  • Nuveen reported no remaining ImageneBio Inc position as of Q2 2024 after selling out during the quarter.
  • Nuveen sold 3,027 ImageneBio Inc shares in Q2 2024, an estimated $51.6K.
  • Nuveen first reported a position in ImageneBio Inc in Q2 2021 and held it in 8 quarters.
  • Nuveen's ImageneBio Inc position peaked at $997K in Q4 2021.
  • 70 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2024.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.